Welcome to LookChem.com Sign In|Join Free

CAS

  • or

172732-78-4

Post Buying Request

172732-78-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

172732-78-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 172732-78-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,2,7,3 and 2 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 172732-78:
(8*1)+(7*7)+(6*2)+(5*7)+(4*3)+(3*2)+(2*7)+(1*8)=144
144 % 10 = 4
So 172732-78-4 is a valid CAS Registry Number.

172732-78-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-benzyl-2-methylindol-4-ol

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:172732-78-4 SDS

172732-78-4Relevant articles and documents

Synthesis and chemical transformation of 2-iodomethyl-1-(phenylmethyl)-1,5, 6,7-tetrahydroindol-4-ones

Mphahlelea, Malose J.,El-Gogary, Tarek M.

experimental part, p. 227 - 231 (2009/08/07)

2-Allyl-3-benzylamino-2-cyclohexenones undergo iodine-methanol-promoted iodocyclisation under reflux to afford products characterised by combination of NMR (1H and 13C), IR and mass spectroscopic techniques as the conjugated iodolium betaine derivatives o

PHOSPHOLIPASE INHIBITORS, INCLUDING MULTI-VALENT PHOSPHOLIPASE INHIBITORS, AND USE THEREOF, INCLUDING AS LUMEN-LOCALIZED PHOSPHOLIPASE INHIBITORS

-

Page/Page column 187-197; 212-213; 216; 219-220; 263-264; 265; 271, (2010/11/27)

The present invention provides methods and compositions for the treatment of phospholipase-related conditions. In particular, the invention provides a method of treating insulin-related, weight-related conditions and/or cholesterol-related conditions in an animal subject. The method generally involves the administration of a non-absorbed and/or effluxed phospholipase A2 inhibitor that is localized in a gastrointestinal lumen.

Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors

-

Page/Page column 91-97; 108-109; 112-115, (2010/11/27)

Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 172732-78-4